Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors-Reference-Cited by-同舟云学术

Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors

Published:2016-01 Issue:2 Volume:24 Page:207-219
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Achary Raghavendra,Yun Jeong In,Park Chi Min,Mathi Gangadhar Rao,Lee Joo Yun,Ha Jae Du,Chae Chong Hak,Ahn Sunjoo,Park Chi Hoon,Lee Chong Ock,Hwang Jong Yeon,Yun Chang-Soo,Jung Hee Jung,Cho Sung Yun,Kim Hyoung Rae,Kim Pilho

Funder

Korea Research Institute of Chemical Technology

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1

2. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

3. The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

4. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent;Anti-Cancer Agents in Medicinal Chemistry;2023-05

2. 3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors;Pharmaceutical Fronts;2022-08-16

3. Research progress on the drug resistance of ALK kinase inhibitors;Current Medicinal Chemistry;2021-08-06

4. The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents;Current Topics in Medicinal Chemistry;2021-07

5. Discovery of methyl 3-((2-((1-(dimethylglycyl)-5-methoxyindolin-6-yl)amino)-5-(trifluoro-methyl) pyrimidin-4-yl)amino)thiophene-2-carboxylate as a potent and selective polo-like kinase 1 (PLK1) inhibitor for combating hepatocellular carcinoma;European Journal of Medicinal Chemistry;2020-11